Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart

J K Kjekshus, O D Mjos, J K Kjekshus, O D Mjos

Abstract

Since elevation of plasma concentrations of free fatty acids (FFA) increases myocardial oxygen consumption without influencing mechanical performance in normal hearts, it was the purpose of this study to determine whether FFA would modify mechanical performance at limited oxygen supply. Left coronary blood flow was reduced by gradual clamping of a shunt from the left carotid artery until moderate ventricular dilatation supervened. Left ventricular systolic pressure (LVSP), its maximal rate of rise (dP/dt) and stroke volume (SV) were unchanged or slightly reduced. The ischemia resulted in a decrease in myocardial oxygen consumption (MVO(2)) from 9.7+/-1.1 ml/min to 7.9+/-0.8 ml/min, and myocardial lactate uptake was reduced or reversed to excretion. Increasing the plasma concentrations of FFA from 359+/-47 muEq/1 to 3688+/-520 muEq/1 by intravenous infusion of a triglyceride emulsion and heparin resulted in further ventricular dilatation, accompanied by increased excretion of lactate. The ventricular decompensation and enhancement of anaerobic myocardial metabolism associated with increased uptake of FFA was not related to changes in coronary flow, MVO(2), or LVSP. dP/dt and SV were virtually unchanged. Intravenous infusion of glucose/insulin, which lowered plasma concentrations of FFA, reversed ventricular dilatation and lactate excretion. The data support the hypothesis that high concentrations of FFA play a significant role in increasing myocardial oxygen requirement and thereby promote depression of contractility of the hypoxic heart in experimental animals.

References

    1. Biochim Biophys Acta. 1956 Sep;21(3):458-66
    1. Scand J Clin Lab Invest. 1971 Dec;28(4):389-93
    1. J Biol Chem. 1968 Dec 10;243(23):6180-5
    1. Lancet. 1968 Apr 6;1(7545):710-4
    1. Ann N Y Acad Sci. 1965 Oct 8;131(1):119-42
    1. Circulation. 1971 Jan;43(1):67-82
    1. Cardiovasc Res. 1970 Oct;4(4):466-72
    1. J Clin Invest. 1971 Sep;50(9):1869-73
    1. J Clin Invest. 1967 Oct;46(10):1657-68
    1. Eur J Clin Invest. 1971 Jan;1(4):225-41
    1. J Clin Invest. 1971 Jul;50(7):1386-9
    1. Metabolism. 1968 Apr;17(4):370-6
    1. Lancet. 1965 Sep 25;2(7413):607-9
    1. Circ Res. 1970 Apr;26(4):439-49
    1. Scand J Clin Lab Invest. 1971 Oct;28(2):127-32
    1. Metabolism. 1966 Oct;15(10):945-54
    1. Lancet. 1963 Apr 13;1(7285):785-9
    1. J Biol Chem. 1964 Jun;239:1694-9
    1. Ann N Y Acad Sci. 1965 Oct 8;131(1):225-34
    1. Scand J Clin Lab Invest. 1969 Dec;24(4):361-71
    1. Am J Physiol. 1963 Feb;204:317-22
    1. Lancet. 1969 Jun 28;1(7609):1315-6
    1. Biochim Biophys Acta. 1962 Aug 27;62:509-18
    1. J Clin Invest. 1968 Feb;47(2):403-16
    1. J Clin Invest. 1956 Feb;35(2):150-4
    1. J Lipid Res. 1960 Apr;1:199-202
    1. Dis Chest. 1963 Apr;43:424-32
    1. Am J Physiol. 1968 Feb;214(2):365-9
    1. Scand J Clin Lab Invest. 1971 Oct;28(2):121-5
    1. Am J Physiol. 1963 Oct;205:781-4
    1. Lancet. 1966 Jul 16;2(7455):122-7
    1. Am J Physiol. 1966 Feb;210(2):280-6
    1. Am J Physiol. 1956 Sep;187(1):135-8
    1. Lancet. 1969 Jun 14;1(7607):1187-90
    1. Scand J Clin Lab Invest. 1962;14:533-6

Source: PubMed

3
Subscribe